ID27276A - Oksazolidinon-oksazolidinon untuk merawat infeksi-infeksi mata - Google Patents
Oksazolidinon-oksazolidinon untuk merawat infeksi-infeksi mataInfo
- Publication number
- ID27276A ID27276A IDW20002687A ID20002687A ID27276A ID 27276 A ID27276 A ID 27276A ID W20002687 A IDW20002687 A ID W20002687A ID 20002687 A ID20002687 A ID 20002687A ID 27276 A ID27276 A ID 27276A
- Authority
- ID
- Indonesia
- Prior art keywords
- treatment
- oksazolidinons
- infections
- eyes
- oxazolidinone
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9276598P | 1998-07-14 | 1998-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID27276A true ID27276A (id) | 2001-03-22 |
Family
ID=22235050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002687A ID27276A (id) | 1998-07-14 | 1999-07-07 | Oksazolidinon-oksazolidinon untuk merawat infeksi-infeksi mata |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US6337329B1 (xx) |
| EP (1) | EP1096934B1 (xx) |
| JP (1) | JP2002520359A (xx) |
| KR (1) | KR20010079530A (xx) |
| CN (1) | CN1305374A (xx) |
| AT (1) | ATE304886T1 (xx) |
| AU (1) | AU740781B2 (xx) |
| BG (1) | BG64666B1 (xx) |
| BR (1) | BR9912004A (xx) |
| CA (1) | CA2334811A1 (xx) |
| DE (1) | DE69927380T2 (xx) |
| DK (1) | DK1096934T3 (xx) |
| EA (1) | EA003274B1 (xx) |
| EE (1) | EE200100026A (xx) |
| ES (1) | ES2249020T3 (xx) |
| HU (1) | HUP0102836A3 (xx) |
| ID (1) | ID27276A (xx) |
| IL (1) | IL140769A0 (xx) |
| NO (1) | NO20010202L (xx) |
| NZ (1) | NZ509375A (xx) |
| PL (1) | PL345544A1 (xx) |
| PT (1) | PT1096934E (xx) |
| SG (1) | SG125079A1 (xx) |
| SK (1) | SK20332000A3 (xx) |
| TR (1) | TR200100066T2 (xx) |
| WO (1) | WO2000003710A1 (xx) |
| ZA (1) | ZA200100038B (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR020660A1 (es) * | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | Composiciones antibioticas para el tratamiento de ojos, oidos y nariz |
| ATE337002T1 (de) * | 1999-09-13 | 2006-09-15 | Insite Vision Inc | Topische behandlung zur vorbeugung von augeninfektionen |
| US6562820B2 (en) * | 2000-07-05 | 2003-05-13 | Pharmacia & Upjohn Company | Method for treatment and prevention of mastitis |
| PE20020300A1 (es) * | 2000-08-22 | 2002-05-10 | Pharmacia Corp | Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco |
| PE20020578A1 (es) | 2000-10-10 | 2002-08-14 | Upjohn Co | Una composicion de antibiotico topico para el tratamiento de infecciones oculares |
| US7125568B2 (en) * | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
| US20030069235A1 (en) * | 2001-09-14 | 2003-04-10 | J. Greg Slatter | Treatment for ocular infections |
| EP1478404A1 (en) * | 2002-02-22 | 2004-11-24 | Pharmacia Corporation | Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride |
| TW201043267A (en) * | 2009-03-19 | 2010-12-16 | Intervet Int Bv | In situ constituting a vaccine for administration to a predetermined herd of animals |
| CN101766628B (zh) * | 2010-01-20 | 2012-07-04 | 广东宏盈科技有限公司 | 一种眼科外用抗细菌感染药物 |
| JP6419701B2 (ja) | 2012-09-13 | 2018-11-07 | スターファーマ・ピーティーワイ・リミテッド | 眼の感染症の治療または予防方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164510A (en) * | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
| US5231188A (en) | 1989-11-17 | 1993-07-27 | The Upjohn Company | Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents |
| WO1993009103A1 (en) * | 1991-11-01 | 1993-05-13 | The Upjohn Company | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| EP0730591B1 (en) * | 1993-11-22 | 1999-07-14 | PHARMACIA & UPJOHN COMPANY | Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| DE4425612A1 (de) * | 1994-07-20 | 1996-04-04 | Bayer Ag | 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone |
| DE4425613A1 (de) | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
| EP0951295B1 (en) * | 1996-05-31 | 2010-06-09 | The Scripps Research Institute | Compositions for use in inhibiting of alpha-v-beta3 mediated angiogenesis |
-
1999
- 1999-07-07 SG SG200300091A patent/SG125079A1/en unknown
- 1999-07-07 US US09/349,430 patent/US6337329B1/en not_active Expired - Fee Related
- 1999-07-07 ID IDW20002687A patent/ID27276A/id unknown
- 1999-07-07 EA EA200100133A patent/EA003274B1/ru unknown
- 1999-07-07 SK SK2033-2000A patent/SK20332000A3/sk unknown
- 1999-07-07 IL IL14076999A patent/IL140769A0/xx unknown
- 1999-07-07 TR TR2001/00066T patent/TR200100066T2/xx unknown
- 1999-07-07 NZ NZ509375A patent/NZ509375A/en unknown
- 1999-07-07 WO PCT/US1999/012367 patent/WO2000003710A1/en not_active Application Discontinuation
- 1999-07-07 CN CN99807427A patent/CN1305374A/zh active Pending
- 1999-07-07 EP EP99933483A patent/EP1096934B1/en not_active Expired - Lifetime
- 1999-07-07 AT AT99933483T patent/ATE304886T1/de not_active IP Right Cessation
- 1999-07-07 JP JP2000559845A patent/JP2002520359A/ja not_active Withdrawn
- 1999-07-07 DK DK99933483T patent/DK1096934T3/da active
- 1999-07-07 CA CA002334811A patent/CA2334811A1/en not_active Abandoned
- 1999-07-07 DE DE69927380T patent/DE69927380T2/de not_active Expired - Fee Related
- 1999-07-07 PT PT99933483T patent/PT1096934E/pt unknown
- 1999-07-07 BR BR9912004-6A patent/BR9912004A/pt not_active Application Discontinuation
- 1999-07-07 HU HU0102836A patent/HUP0102836A3/hu unknown
- 1999-07-07 PL PL99345544A patent/PL345544A1/xx unknown
- 1999-07-07 ES ES99933483T patent/ES2249020T3/es not_active Expired - Lifetime
- 1999-07-07 EE EEP200100026A patent/EE200100026A/xx unknown
- 1999-07-07 AU AU49530/99A patent/AU740781B2/en not_active Ceased
- 1999-07-07 KR KR1020017000567A patent/KR20010079530A/ko not_active Application Discontinuation
-
2001
- 2001-01-02 ZA ZA200100038A patent/ZA200100038B/en unknown
- 2001-01-10 BG BG105142A patent/BG64666B1/bg unknown
- 2001-01-12 NO NO20010202A patent/NO20010202L/no not_active Application Discontinuation
- 2001-09-19 US US09/955,679 patent/US6740652B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60134134D1 (de) | Prophylaktische und therapeutische behandlung von ten mit verbindungen, die auf monosacchariden basieren | |
| DK0867184T3 (da) | Anvendelse af tiagabin til behandling af søvnforstyrrelser | |
| LU91928I2 (fr) | Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®) | |
| DK0880350T3 (da) | Behandling af dissemineret sklerose | |
| DE59802356D1 (de) | Lagerstabile ophthalmische zusammensetzungen, umfassend diclofenac und ofloxacin | |
| BR9814923A (pt) | Método para tratamento de doença de alzheimer | |
| ID27276A (id) | Oksazolidinon-oksazolidinon untuk merawat infeksi-infeksi mata | |
| EA200300560A1 (ru) | Улучшенный способ лечения | |
| DK52487A (da) | Ophthalmisk anvendelse af quinolon- og naphthyri- dinforbindelser | |
| EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
| DK1305037T3 (da) | Smertestillende medikament | |
| SE0004101D0 (sv) | New use | |
| SE9403160D0 (sv) | Method and means for prevention and treatment of secondary cataract | |
| EA200100010A1 (ru) | Местное применение оксазолидинонов для трансдермальной доставки | |
| NO20006087L (no) | Fremgangsmåter for å öke nivåer av acetylcholin | |
| NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
| MX9604692A (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
| NO984196L (no) | FremgangsmÕte for behandling av stoffmisbruk | |
| NO984190L (no) | FremgangsmÕte for behandling av insomnia |